Viewing Study NCT02892045



Ignite Creation Date: 2024-05-06 @ 9:05 AM
Last Modification Date: 2024-10-26 @ 12:09 PM
Study NCT ID: NCT02892045
Status: COMPLETED
Last Update Posted: 2019-06-24
First Post: 2016-08-29

Brief Title: Mindray Neuromuscular Transmission Transducer
Sponsor: Suez Canal University
Organization: Suez Canal University

Study Overview

Official Title: Sensitivity and Specificity of the New Mindray 3-Directional Neuromuscular Transmission Module Versus the Relaxometer Mechanomyograph and Versus TOF-Watch Acceleromyograph for Neuromuscular Block Monitoring
Status: COMPLETED
Status Verified Date: 2019-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NMT1
Brief Summary: A new NMT module from Mindray Mindray Co Shenzhen Peoples Republic of China claims to measure 3 directional accelerography The aim of the study is to compare the neuromuscular block of rocuronium 06 mgkg twice the 95 effective dose ED95 monitored by the NMT versus that monitored by the Relaxometer Mechanomyograph on the other hand in Group 1 and versus the TOF-Watch on the other hand in Group 2 to clinically evaluate the new system for its diagnostic accuracy
Detailed Description: Mechanomyography MMG is regarded as the standard method for precise quantification of neuromuscular block The conventional MMG measures the exact force of muscle contraction in response to electric stimulation of the ulnar nerve MMG quantifies the neuromuscular function by measurement of the force displacement However the equipment is rather bulky takes time to set up requires a rigid support of the arm in an often-crowded operating room This limits its clinical use in the daily anesthesia practice Acceleromyography is based on the acceleration of a piezo-electrode A new NMT module from Shenzhen Peoples Republic of China claims to measure 3 directional accelerography The aim of the study is to compare the neuromuscular block of rocuronium 06 mgkg twice the 95 effective dose ED95 monitored by the NMT to that monitored by the Relaxometer Mechanomyograph in Group 1 and versus TOF-Watch Acceleromyograph in Group 2 to clinically evaluate the new system for its diagnostic accuracy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None